Eyepoint Pharmaceuticals (NASDAQ:EYPT) outlined late-stage clinical progress for its lead retinal candidate DURAVYU and ...

Photobiomodulation with the Valeda light delivery system was authorized in November 2024, and we have been treating patients with it since summer 2025.It seems too simple to be true that we could ...

Of all the skin-care and cosmetics products I recently bought online that turned out to be counterfeit, expired, used, or otherwise problematic, the one that still makes me squirm is a curiously ...

Sports betting has become a staple of the modern sports fan experience and there are plenty of options for prospective users to choose from when it comes to sports betting apps. We'll take a look at ...